Inhibitors of PIM-1 Kinase: A Computational Analysis of the Binding Free Energies of a Range of Imidazo [1, 2-b] Pyridazines
暂无分享,去创建一个
Raman Sharma | Richard H. Henchman | Slimane Doudou | David W. Sheppard | Neil A. Burton | N. Burton | D. Sheppard | Raman Sharma | S. Doudou
[1] C. Homon,et al. Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode. , 2009, Journal of medicinal chemistry.
[2] S. Knapp,et al. Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity. , 2007, Cancer research.
[3] M. Lilly,et al. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase. , 2007, Bioorganic & medicinal chemistry.
[4] S. Knapp,et al. A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases , 2007, Proceedings of the National Academy of Sciences.
[5] I. W. Cheney,et al. Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase. , 2007, Bioorganic & medicinal chemistry letters.
[6] Eric F. Johnson,et al. Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling. , 2008, Bioorganic & medicinal chemistry letters.
[7] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[8] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[9] M. Fleming,et al. Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002* , 2005, Journal of Biological Chemistry.
[10] Richard J. Dimelow,et al. Exploring reaction pathways with transition path and umbrella sampling: application to methyl maltoside. , 2006, The Journal of chemical physics.
[11] Richard H. Henchman,et al. Standard Free Energy of Binding from a One-Dimensional Potential of Mean Force. , 2009, Journal of chemical theory and computation.
[12] Gavin Harper,et al. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. , 2008, Journal of medicinal chemistry.
[13] A. Kraft,et al. Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. , 2009, Journal of medicinal chemistry.
[14] S. Knapp,et al. Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. , 2005, Journal of medicinal chemistry.
[15] N. Gray,et al. Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.
[16] A. Pierce,et al. Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase. , 2008, Journal of medicinal chemistry.
[17] B. Werneburg,et al. Pim kinase substrate identification and specificity. , 2006, Journal of biochemistry.
[18] R. Swendsen,et al. THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .
[19] Daumantas Matulis,et al. Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. , 2005, Biochemistry.
[20] M. Lilly,et al. Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase , 2007, Molecular Cancer Therapeutics.
[21] K. Kaibuchi,et al. Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y-27632. , 2006, Journal of biochemistry.
[22] Toshio Hakoshima,et al. A molecular mechanism of P-loop pliability of Rho-kinase investigated by molecular dynamic simulation , 2008, J. Comput. Aided Mol. Des..
[23] L. Michelle. Chapter 13 Targeting the Kinome with Computational Chemistry , 2005 .
[24] P. Cohen,et al. The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.
[25] Yoshihisa Suzuki,et al. Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma. , 2005, Journal of molecular biology.
[26] T. Tsuruo,et al. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. , 2008, Cancer research.
[27] M. Salto‐Tellez,et al. Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. , 2008, European journal of cancer.